Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
Ritsinger V, Malmberg K, Mårtensson A, Rydén L, Wedel H, Norhammar A. Ritsinger V, et al. Lancet Diabetes Endocrinol. 2014 Aug;2(8):627-33. doi: 10.1016/S2213-8587(14)70088-9. Epub 2014 May 13. Lancet Diabetes Endocrinol. 2014. PMID: 24831989 Clinical Trial.
Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Ritsinger V, Tanoglidi E, Malmberg K, Näsman P, Rydén L, Tenerz Å, Norhammar A. Ritsinger V, et al. Diab Vasc Dis Res. 2015 Jan;12(1):23-32. doi: 10.1177/1479164114551746. Epub 2014 Oct 13. Diab Vasc Dis Res. 2015. PMID: 25311248 Free article.
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Smaradottir MI, Ritsinger V, Gyberg V, Norhammar A, Näsman P, Mellbin LG. Smaradottir MI, et al. Among authors: ritsinger v. Diab Vasc Dis Res. 2017 Mar;14(2):69-76. doi: 10.1177/1479164116664490. Epub 2017 Jan 24. Diab Vasc Dis Res. 2017. PMID: 28118730 Free article.
Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohort.
Ritsinger V, Brismar K, Mellbin L, Näsman P, Rydén L, Söderberg S, Norhammar A. Ritsinger V, et al. Diab Vasc Dis Res. 2018 Sep;15(5):387-395. doi: 10.1177/1479164118781892. Epub 2018 Jul 11. Diab Vasc Dis Res. 2018. PMID: 29992830 Free article.
Elevated admission glucose is common and associated with high short-term complication burden after acute myocardial infarction: Insights from the VALIDATE-SWEDEHEART study.
Ritsinger V, Jensen J, Ohm D, Omerovic E, Koul S, Fröbert O, Erlinge D, James S, Lagerqvist B, Norhammar A. Ritsinger V, et al. Diab Vasc Dis Res. 2019 Nov;16(6):582-584. doi: 10.1177/1479164119871540. Epub 2019 Sep 3. Diab Vasc Dis Res. 2019. PMID: 31476896 Free article. Clinical Trial.
21 results